病例量与综合卒中中心能力对蛛网膜下腔出血夹闭和栓塞患者结局的影响
基于日本全国J-ASPECT诊断程序组合数据库的回顾性队列研究,纳入2010至2015年间621家机构中27,490例接受夹闭或栓塞治疗的蛛网膜下腔出血患者。按病例量和综合卒中中心评分(1-25分)四分位分组,分析其与院内死亡和短期不良结局的关系。结果显示病例量和综合卒中中心能力对夹闭与栓塞患者结局的影响不同。
要点
- 夹闭患者高病例量(>14例/年)与院内死亡降低相关(Q4 OR 0.71,95%CI 0.55-0.90),但与短期不良结局无关。
- 栓塞患者高病例量(>9例/年)与院内死亡降低(Q4 OR 0.69,95%CI 0.53-0.90)和短期不良结局降低相关。
- 高综合卒中中心评分(>19分)与夹闭患者院内死亡降低相关(OR 0.68,95%CI 0.54-0.86),与栓塞治疗无关。
核心结论
- 病例量和综合卒中中心能力对蛛网膜下腔出血患者院内死亡和短期功能结局的影响在夹闭与栓塞患者间存在差异。
- 在現代血管内治疗时代,高综合卒中中心能力的机构可能实现更好的夹闭结局。
研究设计与样本
- 日本全国回顾性队列研究,纳入2010至2015年间621家机构中27,490例接受夹闭或栓塞治疗的蛛网膜下腔出血患者,数据来自J-ASPECT诊断程序组合数据库。
- 医院综合卒中中心能力采用基于25项问卷的验证评分系统(评分1-25分)评估,并按评分和病例量四分位分组。
主要发现
- 夹闭患者中,高病例量(>14例/年)与院内死亡降低显著相关(以Q1为对照,Q4 OR 0.71,95%CI 0.55-0.90),但与短期不良结局无关。
- 栓塞患者中,高病例量(>9例/年)与院内死亡降低相关(Q4 OR 0.69,95%CI 0.53-0.90),并与短期不良结局降低相关(Q3 [>5例/年] OR 0.75,95%CI 0.59-0.96;Q4 OR 0.65,95%CI 0.51-0.82)。
- 高综合卒中中心评分(>19分)与夹闭患者院内死亡降低显著相关(OR 0.68,95%CI 0.54-0.86),但与栓塞治疗无关。
- 综合卒中中心能力与短期不良结局之间无关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Improved outcomes in patients with subarachnoid hemorrhage (SAH) treated at high-volume centers have been reported. The authors sought to examine whether hospital case volume and comprehensive stroke center (CSC) capabilities affect outcomes in patients treated with clipping or coiling for SAH. METHODS: The authors conducted a nationwide retrospective cohort study in 27,490 SAH patients who underwent clipping or coiling in 621 institutions between 2010 and 2015 and whose data were collected from the Japanese nationwide J-ASPECT Diagnosis Procedure Combination database. The CSC capabilities of each hospital were assessed by use of a validated scoring system based on answers to a previously reported 25-item questionnaire (CSC score 1-25 points). Hospitals were classified into quartiles based on CSC scores and case volumes of clipping or coiling for SAH. RESULTS: Overall, the absolute risk reductions associated with high versus low case volumes and high versus low CSC scores were relatively small. Nevertheless, in patients who underwent clipping, a high case volume (> 14 cases/yr) was significantly associated with reduced in-hospital mortality (Q1 as control, Q4 OR 0.71, 95% CI 0.55-0.90) but not with short-term poor outcome. In patients who underwent coiling, a high case volume (> 9 cases/yr) was associated with reduced in-hospital mortality (Q4 OR 0.69, 95% CI 0.53-0.90) and short-term poor outcomes (Q3 [> 5 cases/yr] OR 0.75, 95% CI 0.59-0.96 vs Q4 OR 0.65, 95% CI 0.51-0.82). A high CSC score (> 19 points) was significantly associated with reduced in-hospital mortality for clipping (OR 0.68, 95% CI 0.54-0.86) but not coiling treatment. There was no association between CSC capabilities and short-term poor outcomes. CONCLUSIONS: The effects of case volume and CSC capabilities on in-hospital mortality and short-term functional outcomes in SAH patients differed between patients undergoing clipping and those undergoing coiling. In the modern endovascular era, better outcomes of clipping may be achieved in facilities with high CSC capabilities.
引用
- Kurogi R, Kada A, Ogasawara K, et al. Effects of case volume and comprehensive stroke center capabilities on patient outcomes of clipping and coiling for subarachnoid hemorrhage. J Neurosurg. 2020. PMID: 32168489. doi:10.3171/2019.12.JNS192584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。